{
    "clinical_study": {
        "@rank": "40227", 
        "arm_group": [
            {
                "arm_group_label": "Whey protein", 
                "arm_group_type": "Experimental", 
                "description": "Whey protein was provided as sachets with 15g. Patients were advised to consume two sachets per day (amounting to 22.4g of protein) mixed with food or a cold beverage, for 16 weeks. All patients remained on an unrestricted diet and did not receive nutritional advice."
            }, 
            {
                "arm_group_label": "Soy protein", 
                "arm_group_type": "Active Comparator", 
                "description": "Soy protein was provided as sachets with 15g. Patients were advised to consume two sachets per day (amounting to 22.4g of protein) mixed with food or a cold beverage, for 16 weeks. All patients remained on an unrestricted diet and did not receive nutritional advice."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study was to evaluate the effect of Whey Protein (WP) and Soy Protein\n      (SP) nutritional supplements on nutritional status and disease activity in Crohn's disease\n      patients."
        }, 
        "brief_title": "Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Crohn's Disease", 
        "condition_browse": {
            "mesh_term": "Crohn Disease"
        }, 
        "detailed_description": {
            "textblock": "The patients were split into two groups: one group was supplemented with whey protein and\n      the other, with soy protein. Participants were assessed at three moments: before starting\n      the intervention and after 8 and 16 weeks. The nutritional status and body composition were\n      measured using bioimpedance analysis, anthropometry and albumin and pre-albumin dosages.\n      Dietary intake was determined by 24-h dietary recalls. The disease activity was evaluated by\n      Crohn's Disease Activity Index, serum cytokines and C-reactive protein dosages."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Crohn's disease patients treated with azathioprine or anti-tumor necrosis\n             factor-alpha (anti-TNF-alpha) or azathioprine and anti-TNF-alpha\n\n        Exclusion Criteria:\n\n          -  smokers\n\n          -  who were using other medication or nutritional supplements."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "41", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957423", 
            "org_study_id": "CAAE: 1099.0.146.000-11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Whey protein", 
                "description": "Whey protein was provided as sachets with 15g. Patients were advised to consume two sachets per day (amounting to 22.4g of protein) mixed with food or a cold beverage, for 16 weeks. All patients remained on an unrestricted diet and did not receive nutritional advice.", 
                "intervention_name": "Whey protein", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Soy protein", 
                "description": "Soy protein was provided as sachets with 15g. Patients were advised to consume two sachets per day (amounting to 22.4g of protein) mixed with food or a cold beverage, for 16 weeks. All patients remained on an unrestricted diet and did not receive nutritional advice.", 
                "intervention_name": "Soy protein", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Crohn's disease", 
            "whey protein", 
            "soy protein", 
            "nutritional status", 
            "activity of disease"
        ], 
        "lastchanged_date": "September 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Campinas", 
                    "country": "Brazil", 
                    "state": "Sao Paulo", 
                    "zip": "13083-970"
                }, 
                "name": "University of Campinas"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Immune Response Regulation and Nutritional Status of Crohn's Disease Patients Under Anti-TNF-alpha and Azathioprine Therapy.", 
        "overall_official": {
            "affiliation": "University of Campinas", 
            "last_name": "Maria MS Vilela, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Body mass index (BMI) was calculated from weight and height (kilograms per meter squared) and classified according to the World Health Organization.", 
            "measure": "Body mass index", 
            "safety_issue": "No", 
            "time_frame": "16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957423"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Campinas, Brazil", 
            "investigator_full_name": "PhD Maria Marluce dos Santos Vilela", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Body fat was measured using bioimpedance analysis. Whole-body resistance and reactance were measured using a tetrapolar bioelectrical impedance analyzer in accordance with the manufacturer's guidelines (BIODYNAMICS, Model 310e).", 
                "measure": "Body fat percentage", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "The body lean mass was measured using bioimpedance analysis. Whole-body resistance and reactance were measured using a tetrapolar bioelectrical impedance analyzer in accordance with the manufacturer's guidelines (BIODYNAMICS, Model 310e).", 
                "measure": "Body lean percentage", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Mid-arm circumference was obtained using the tape measure.", 
                "measure": "Mid-arm circumference", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Mid-arm muscle circumference was calculated from mid-arm circumference and triceps skin fold thickness.", 
                "measure": "Mid-arm muscle circumference", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Corrected arm muscle area was calculated from mid-arm circumference and triceps skin fold thickness.", 
                "measure": "Corrected arm muscle area", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "The Crohn's Disease Activity Index was used for evaluation of disease activity.", 
                "measure": "Crohn's Disease Activity Index", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "measure": "C-reactive protein", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "measure": "Serum albumin", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "measure": "Pre-albumin", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }, 
            {
                "description": "Triceps skin fold thickness was obtained using the Lange skin fold caliper.", 
                "measure": "Triceps skin fold thickness", 
                "safety_issue": "No", 
                "time_frame": "16 weeks"
            }
        ], 
        "source": "University of Campinas, Brazil", 
        "sponsors": {
            "collaborator": {
                "agency": "Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Campinas, Brazil", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}